Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank31
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P31
Within normal range
vs 3Y Ago
-2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-75.10%
2024-8.08%
2023-29.40%
202237.78%
202154.41%
2020-59.28%
2019-35.87%
2018-74.27%
2017-62.94%
2016-125.73%